Matthew Fry

Director/Board Member at PARADIGM BIOPHARMACEUTICALS LIMITED

Net worth: 1 M $ as of 30/06/2026

Health Technology

Profile

Mr. Matthew Fry is a Chief Executive Officer & Managing Director at Am Diagnostics Pty Ltd. He is on the Board of Directors at Paradigm Biopharmaceuticals Ltd.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BLINKLAB LIMITED 1.85%	21/08/2025	28,33,333 ( 1.85% )	1 M $	30/06/2026
PARADIGM BIOPHARMACEUTICALS LTD. 0.27%	02/06/2026	15,96,300 ( 0.27% )	182 473 $	30/06/2026

Matthew Fry active positions

Companies	Position	Start
PARADIGM BIOPHARMACEUTICALS LIMITED	Director/Board Member	04/03/2024

All active positions of Matthew Fry

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Fry's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Paradigm Biopharmaceuticals Ltd. Paradigm Biopharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Engages in repurposing the drug, pentosan polysulphate sodium for the treatment of bone marrow edema	Health Technology

See company connections